Impact of Centralizing Care for Genitourinary Malignancies to High-volume Providers: A Systematic Review

被引:83
作者
Williams, Stephen B. [1 ]
Ray-Zack, Mohamed D. [1 ]
Hudgins, Hogan K. [1 ]
Oldenburg, Jan [2 ]
Quoc-Dien Trinh [3 ]
Nguyen, Paul L. [4 ]
Shore, Neal D. [5 ]
Wirth, Manfred P. [6 ]
O'Brien, Timothy [7 ]
Catto, James W. F. [8 ]
机构
[1] Univ Texas Med Branch, Div Urol, 301 Univ Blvd, Galveston, TX 77555 USA
[2] Akershus Univ Hosp, Dept Oncol, Lorenskog, Norway
[3] Harvard Med Sch, Ctr Surg & Publ Hlth, Brigham & Womens Hosp, Div Urol Surg, Boston, MA 02115 USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA
[5] Carolina Urol Res Ctr, Dept Urol, Myrtle Beach, SC USA
[6] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Urol, Dresden, Germany
[7] Guys & St Thomas NHS Fdn Trust, London, England
[8] Univ Sheffield, Acad Urol Unit, Sheffield, S Yorkshire, England
来源
EUROPEAN UROLOGY ONCOLOGY | 2019年 / 2卷 / 03期
关键词
Centralization; Use; Genitourinary; Urology; Cancer; Utilization; Outcomes; Survival; IMPROVING OUTCOMES GUIDANCE; RADICAL CYSTECTOMY; HOSPITAL VOLUME; BLADDER-CANCER; TESTICULAR CANCER; PENILE CANCER; TRAVEL DISTANCE; PROSTATECTOMY; MORTALITY; MANAGEMENT;
D O I
10.1016/j.euo.2018.10.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Context: The centralization of cancer care is associated with better clinical outcomes and may be a method for optimizing value-based health care systems. Objective: To systematically review the literature regarding the impact of centralization of care on clinical outcomes for genitourinary malignancies. Evidence acquisition: A systematic review was conducted using Ovid and MEDLINE to identify studies between 1970 and 2018 reporting on the centralization of care for genitourinary malignancies. Prospective and retrospective studies were screened. Evidence synthesis: There were no published randomized control trials (RCTs) on the centralization of care for genitourinary malignancies. Twenty-two retrospective studies met inclusion criteria. Centralization of radical cystectomy was the most studied. Care for bladder cancer, prostate cancer, penile cancer, testicular cancer, and renal cancer was reportedly associated with better morbidity and survival outcomes for patients treated at high-volume centers. However, evidence of better outcomes for centralization of care remains limited for penile, renal, and testicular cancers owing to the paucity of data and/or the lower incidence of these genitourinary malignancies. Conclusions: Care for genitourinary malignancies by high-volume providers was associated with greater utilization of cancer surgery, lower morbidity, and better survival outcomes. Centralization of care was most appropriate for complex procedures such as radical cystectomy when interpreted in the context of survival outcomes. Further research is needed to address the impact of centralizing care for all urologic malignancies with consideration of the associated costs and patient-reported measures, including quality of life and patient experience. Patient summary: We explored the evidence for moving major operations into larger centers. We focused on surgery for cancers of the bladder, prostate, testicle, penis, and kidney, and found that larger-volume hospitals had better survival outcomes and fewer complications when compared to smaller hospitals. The difference may be greatest for complex major surgeries such as radical cystectomy. (C) 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:265 / 273
页数:9
相关论文
共 49 条
  • [1] Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance': the case for super centralisation
    Afshar, Mehran
    Goodfellow, Henry
    Jackson-Spence, Francesca
    Evison, Felicity
    Parkin, John
    Bryan, Richard T.
    Parsons, Helen
    James, Nicholas D.
    Patel, Prashant
    [J]. BJU INTERNATIONAL, 2018, 121 (02) : 217 - 224
  • [2] EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
    Babjuk, Marko
    Burger, Maximilian
    Zigeuner, Richard
    Shariat, Shahrokh F.
    van Rhijn, Bas W. G.
    Comperat, Eva
    Sylvester, Richard J.
    Kaasinen, Eero
    Boehle, Andreas
    Palou Redorta, Joan
    Roupret, Morgan
    [J]. EUROPEAN UROLOGY, 2013, 64 (04) : 639 - 653
  • [3] The influence of hospital volume on survival after resection for lung cancer
    Bach, PB
    Cramer, LD
    Schrag, D
    Downey, RJ
    Gelfand, SE
    Begg, CB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) : 181 - 188
  • [4] The impact of Improving Outcomes Guidance on the management and outcomes of patients with carcinoma of the penis
    Bayles, Andrew C.
    Sethia, Krishna K.
    [J]. ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2010, 92 (01) : 44 - 45
  • [5] Variations in morbidity after radical prostatectomy.
    Begg, CB
    Riedel, ER
    Bach, PB
    Kattan, MW
    Schrag, D
    Warren, JL
    Scardino, PT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15) : 1138 - 1144
  • [6] Variations among high volume surgeons in the rate of complications after radical prostatectomy: Further evidence that technique matters
    Bianco, FJ
    Riedel, ER
    Begg, CB
    Kattan, MIW
    Scardino, PT
    [J]. JOURNAL OF UROLOGY, 2005, 173 (06) : 2099 - 2103
  • [7] Hospital volume and surgical mortality in the United States.
    Birkmeyer, JD
    Siewers, AE
    Finlayson, EVA
    Stukel, TA
    Lucas, FL
    Batista, I
    Welch, HG
    Wennberg, DE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (15) : 1128 - 1137
  • [8] Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline
    Chang, Sam S.
    Bochner, Bernard H.
    Chou, Roger
    Dreicer, Robert
    Kamat, Ashish M.
    Lerner, Seth P.
    Lotan, Yair
    Meeks, Joshua J.
    Michalski, Jeff M.
    Morgan, Todd M.
    Quale, Diane Z.
    Rosenberg, Jonathan E.
    Zietman, Anthony L.
    Holzbeierlein, Jeffrey M.
    [J]. JOURNAL OF UROLOGY, 2017, 198 (03) : 552 - 559
  • [9] Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
    Chang, Sam S.
    Boorjian, Stephen A.
    Chou, Roger
    Clark, Peter E.
    Daneshmand, Siamak
    Konety, Badrinath R.
    Pruthi, Raj
    Quale, Diane Z.
    Ritch, Chad R.
    Seigne, John D.
    Skinner, Eila Curlee
    Smith, Norm D.
    McKiernan, James M.
    [J]. JOURNAL OF UROLOGY, 2016, 196 (04) : 1021 - 1029
  • [10] Association Between Treatment at a High-Volume Facility and Improved Survival for Radiation-Treated Men With High-Risk Prostate Cancer
    Chen, Yu-Wei
    Mahal, Brandon A.
    Muralidhar, Vinayak
    Nezolosky, Michelle
    Beard, Clair J.
    Den, Robert B.
    Feng, Felix Y.
    Hoffman, Karen E.
    Martin, Neil E.
    Orio, Peter F.
    Nguyen, Paul L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 683 - 690